±Þ¼º°ñ¼ö¼º¹éÇ÷º´ ȯÀÚÀÇ °ø°í¿ä¹ý¿¡¼ CytarabineÀÇ ¿ë·®ÀÌ ¿¹ÈÄ¿¡ ¹ÌÄ¡´Â ¿µÇâ
Prognostic Implications of Cytarabine Dose in Consolidation Chemotherapy for the Patients with Acute Myelogenous Leukemia
¼Ò¼Ó »ó¼¼Á¤º¸
ÀÌÁ¤Èñ/Jung-Hee Lee
ÀÌÁ¦È¯/À̱ÔÇü/¹æÇý½Â/¾ÈÁøÈñ/ÀÌÁ¤½Å/±è»óÈñ/±è¿ì°Ç/Je-Hwan Lee/Kyoo-Hyung Lee/Hyeseung Bahng/Jin-Hee Ahn/Jung-Shin Lee/Sang-Hee Kim/Woo-Kun Kim
KMID : 0360320000320050954
Abstract
[ÃʷϾøÀ½:No abstract]
Å°¿öµå
Cytarabine; Dose; Consolidation chemotherapy; Acute myelogenous leukemia;
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸